Beres Laura K, Chabela Mammatli, Masitha Matseliso, Catanzarite Zachary, Tukei Vincent J, Mofenson Lynne, Tiam Appolinaire, Greenberg Lauren, Mokone Majoalane, Thabelo Ramatlapeng, Nchephe Masepeli, Mots'oane Tsietso, Guay Laura, Knowlton Amy R
Johns Hopkins University, Bloomberg School of Public Health, Department of International Health, Baltimore, MD, USA.
Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
BMC Health Serv Res. 2024 Dec 18;24(1):1590. doi: 10.1186/s12913-024-12049-x.
Reducing perinatal HIV transmission and optimizing maternal and child health (MCH) outcomes in high HIV prevalence settings is an urgent, but complex, priority. Extant interventions over-emphasize individual-level provider and patient behaviors, and neglect critical health systems-level changes. The 'Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)' study implemented a three-part, patient-centered, health-systems-level intervention to improve MCH and HIV outcomes in Lesotho. Ensuring intervention fit within the health systems context is important, but often overlooked. This manuscript describes implementation research conducted to tailor and adapt intervention implementation to optimize appropriateness, acceptability, and feasibility. It identifies resulting implementation variation across study sites and lessons learned.
The research team reviewed intervention implementation documentation and conducted structured reflections to: 1) assess implementation strategy adaptations, 2) identify facility-specific strategies employed to improve the MCH patient experience, and 3) synthesize lessons.
Facility-based, integrated, multi-disciplinary management teams (MDT) were feasible and acceptable to establish through engagement with facility leadership and facilitation of a participatory training curriculum that established shared values between cadres supporting MCH, and identified facility-specific service delivery gaps and potential solutions. Ongoing MDT meetings provided coordination between facility and community-based MCH service providers to implement early ANC follow-up. Facility-specific improvement strategies included fee, staffing, and patient documentation-based changes. Piloting Positive Health, Dignity, and Prevention-focused counseling approaches resulted in tailored job aids pre-implementation. Leadership involvement was critical for improved coordination while staff turnover and competing donor priorities challenged MDT efforts.
IMPROVE created facility-specific adaptation opportunities through participatory intervention implementation practices. The MDTs, benefitting from leadership support, built relationships between HCW cadres, led facility-specific quality improvements, and, importantly, offered HCWs sought-after positive feedback by recognizing HCW efforts. The coordination, monitoring and cross-cadre communication functions of the MDTs supported implementation of other interventions, and may serve as a valuable platform for improving patient-centered care practices in similar settings and for other health services.
NCT04598958, 05 October 2020, retrospectively registered.
ClinicalTrials.gov, NCT04598958. Registered 05 October 2020-Retrospectively registered, https://clinicaltrials.gov/ct2/show/record/NCT04598958.
在艾滋病毒高流行地区减少围产期艾滋病毒传播并优化母婴健康(MCH)结局是一项紧迫但复杂的优先事项。现有的干预措施过度强调个体层面的医护人员和患者行为,而忽视了关键的卫生系统层面的变革。“改善母婴结局综合管理团队(IMPROVE)”研究实施了一项由三部分组成的、以患者为中心的卫生系统层面干预措施,以改善莱索托的母婴健康和艾滋病毒相关结局。确保干预措施与卫生系统背景相契合很重要,但往往被忽视。本手稿描述了为调整和适应干预措施实施而进行的实施研究,以优化其适宜性、可接受性和可行性。它确定了各研究地点在实施过程中出现的差异以及吸取的经验教训。
研究团队审查了干预措施实施文件,并进行了结构化反思,以:1)评估实施策略的调整;2)确定为改善母婴健康患者体验而采用的特定机构策略;3)总结经验教训。
通过与机构领导层合作并推动参与式培训课程,建立以机构为基础的综合多学科管理团队(MDT)是可行且可接受的,该培训课程在支持母婴健康的不同医护人员群体之间建立了共同价值观,并确定了特定机构的服务提供差距和潜在解决方案。持续开展的MDT会议为机构和社区层面的母婴健康服务提供者之间的协调提供了支持,以实施早期产前检查随访。特定机构的改进策略包括基于费用、人员配备和患者文件的变更。试点以积极健康、尊严和预防为重点的咨询方法,在实施前产生了量身定制的工作辅助工具。领导层的参与对于改善协调至关重要,而人员流动和捐助方相互竞争的优先事项对MDT的工作构成了挑战。
IMPROVE通过参与式干预措施实施实践创造了特定机构的适应机会。MDT在领导层的支持下,在医护人员群体之间建立了关系,引领了特定机构的质量改进,重要的是,通过认可医护人员的努力,为他们提供了备受期待的积极反馈。MDT的协调、监测和跨群体沟通功能支持了其他干预措施的实施,并可能成为在类似环境中改善以患者为中心的护理实践以及其他卫生服务的宝贵平台。
NCT04598958,2020年10月5日,追溯注册。
ClinicalTrials.gov,NCT04598958。2020年10月5日注册——追溯注册,https://clinicaltrials.gov/ct2/show/record/NCT04598958 。